| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate |
2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c139542000784f4e980530939d2b7612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc2fd39a10da22f1d2416ba42c8e0d50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e00e96e30994ea525fbc2fd058cd8b0 |
| publicationDate |
2008-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101120005-A |
| titleOfInvention |
Thiazolopyrimidine compounds for the modulation of chemokine receptor activity |
| abstract |
A compound of formula (I), or a pharmaceutically acceptable salt, or solvate thereof; and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018233648-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103145739-A |
| priorityDate |
2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |